SLC7A11 and breast carcinoma: In addition, Metformin a commonly used hypoglycemic drugs in clinical practice, was found to promote ferroptosis in breast cancer cells by inhibiting the UFMylation of SLC7A11 and the transcription of GPX4 (Yang J. et al., 2021; Hou et al., 2021).